OTCMKTS:AYTU
Aytu Bioscience Stock News
$2.79
-0.0833 (-2.90%)
At Close: Apr 18, 2024
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
09:00am, Wednesday, 03'rd Apr 2024
Webcasted presentation to take place at 4:40 p.m. Eastern time DENVER, CO / ACCESSWIRE / April 3, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
10:52pm, Wednesday, 14'th Feb 2024
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
04:15pm, Wednesday, 07'th Feb 2024
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its finan
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
07:30pm, Tuesday, 14'th Nov 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q1 2024 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Robert Blum - IR Josh Disbrow - CEO Mark Oki - CFO Conference Call Participants N
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
04:15pm, Tuesday, 07'th Nov 2023
DENVER, CO / ACCESSWIRE / November 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financial r
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
04:15pm, Monday, 09'th Oct 2023
ENGLEWOOD, CO / ACCESSWIRE / October 9, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that
Best Penny Stocks? 4 Hot Stocks With News This Week
11:55am, Thursday, 28'th Sep 2023
What do you consider the best penny stocks? Are they the ones exploding higher within a single session?
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
07:01pm, Wednesday, 27'th Sep 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2023 Earnings Call Transcript September 27, 2023 4:30 PM ET Company Participants Robert Blum - IR Josh Disbrow - CEO Mark Oki - CFO Conference Call Participants
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
08:25pm, Thursday, 21'st Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financ
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
08:00am, Wednesday, 13'th Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 13, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced th
Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript
09:57pm, Thursday, 11'th May 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q3 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - Chief
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
04:30pm, Thursday, 04'th May 2023
ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescri
Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript
09:35pm, Tuesday, 21'st Feb 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q2 2023 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - C
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023
03:00pm, Tuesday, 21'st Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused p
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
08:00am, Tuesday, 07'th Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused pr
